Susan Jones‐Bolin
- Co-authors
- Bruce RuggeriCraig A. DionneKam-Fai TseMark J. LevisB. Douglas SmithDonald SmallRui ZhengBrenda R. Baldwin
- Topics
- Angiogenesis and VEGF in Cancer (4 papers)Cancer Research and Treatments (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Susan Jones‐Bolin
13 papers receiving 745 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 424
- Hematology 339
- Genetics 185
- Oncology 184
- Cellular and Molecular Neuroscience 113
Countries citing papers authored by Susan Jones‐Bolin
This map shows the geographic impact of Susan Jones‐Bolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Jones‐Bolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Jones‐Bolin more than expected).
Fields of papers citing papers by Susan Jones‐Bolin
This network shows the impact of papers produced by Susan Jones‐Bolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Jones‐Bolin. The network helps show where Susan Jones‐Bolin may publish in the future.
Co-authorship network of co-authors of Susan Jones‐Bolin
This figure shows the co-authorship network connecting the top 25 collaborators of Susan Jones‐Bolin. A scholar is included among the top collaborators of Susan Jones‐Bolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Jones‐Bolin. Susan Jones‐Bolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 37 | |
| 3 | 38 | |
| 4 | CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models | 2 |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 38 | |
| 9 | Trk inhibitors provide better efficacy than a VEGF-R kinase inhibitor in combination with gemcitabine on improving survival in an orthotopic model of human PDAC | 1 |
| 10 | 139 | |
| 11 | CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth. | 83 |
| 12 | Retinal Vascular Leakage in Early Diabetes is Normalized In Vivo by the Oral VEGF Receptor Kinase Inhibitor, CEP-7055 | 1 |
| 13 | 378 | |
| 14 | 15 |
About Susan Jones‐Bolin
Susan Jones‐Bolin is a scholar working on Biotechnology, Oncology and Toxicology, having authored 14 papers that have together received 769 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Cancer Research and Treatments (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (339 citations), Genetics (185 citations) and Oncology (184 citations). Susan Jones‐Bolin has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Bruce Ruggeri, Craig A. Dionne, Kam-Fai Tse, Mark J. Levis, B. Douglas Smith, Donald Small, Rui Zheng, Brenda R. Baldwin, Kathryn Hunter and Hugh Zhao. Their work appears in journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.